Ai: Both the ON and the OFF portions of light-evoked (λ=505 nm, I=1.95×1012 photons cm−2s−1, 500 ms) L-IPSCs were reduced by the group III mGluR agonist L-AP4 (10–20 µM, red trace). Average traces are shown for each condition (n=5). Aii: Quantification of the effect of L-AP4 on the ON and OFF L-IPSCs charge transfer. L-AP4 significantly reduced ON LIPSC charge (*p<0.02, paired Student’s t-test, two-tailed), but the reduction of OFF L-IPSCs was not significant (p< 0.13, paired Student’s t-test, two-tailed). Measurements, analysis and presentation of drug effects on L-IPSCs are performed this way throughout the paper. Bi: The AMPAR/KAR antagonist NBQX (10 µM, red trace) substantially reduced the OFF L-IPSCs evoked by bright white light (400 ms, I=7.32*1013 photons*cm−2*s−1), but markedly increased the ON L-IPSCs. Bii: Quantification of the NBQX effect on ON and OFF L-IPSC charge transfers. NBQX significantly reduced the OFF L-IPSCs (**: p<0.0001, paired Student’s t-test, two-tailed), and significantly enhanced the ON L-IPSCs (*: p<0.03, paired Student’s t-test, two-tailed). Ci: L-IPSCs were essentially eliminated by the combination of ionotropic glutamate receptor antagonists NBQX (AMPAR/KAR, 10 µM) and (R)-CPP (NMDAR, 20 µM) (red trace). Cii: Quantification of the effect of combined ionotropic glutamate receptor antagonists (NBQX +(R)-CPP, “N+C”) on the ON and OFF L-IPSCs. (R)-CPP +NBQX significantly reduced both the ON and OFF components of the red light (λ=660 nm, 500 ms, I=2.02*1012 photons*cm−2*s−1) evoked L-IPSCs’ charge (*p<0.05, paired Student’s t-test). D: Summary diagram of normalized effects of pharmacological agents affecting retinal glutamatergic signaling on light-evoked L-IPSCs. Data is presented as mean± SE.